Péter Ferdinandy, MD, PhD, MBA, FESC, FISHR has been recognized as Highly Cited Researcher in 2014, 2017, 2020, 2021, and 2022. He published more than 400 papers and 6 patent families. His work is cited more than 28000 times and his Hirsh index is 85. He received an MD diploma in 1991, a PhD in 1995, and an MBA in finance and quality management in 2004. He became a registered clinical pharmacologist in 1999. He did a postdoctoral training at the University of Alberta, Edmonton, Canada (1997-1999). He founded Pharmahungary Group, a group of R&D companies (www.pharmahungary.com) involved in more than 350 drug/medical device development projects since their foundation in the early 2000s. Currently he is the director of the Department of Pharmacology and Pharmacotherapy, the vice-rector for science and innovations, Semmelweis University, Budapest, Hungary (www.semmelweis.hu). He is the editor-in-chief of the British Journal of Pharmacology since 2023.
